{"id":"https://openalex.org/W4361922014","doi":"https://doi.org/10.1158/1078-0432.22462767.v1","title":"SFigure 3 from Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival","display_name":"SFigure 3 from Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361922014","doi":"https://doi.org/10.1158/1078-0432.22462767.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22462767.v1","doi":"https://doi.org/10.1158/1078-0432.22462767.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22462767.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/SFigure_3_from_Macropinocytosis_of_Bevacizumab_by_Glioblastoma_Cells_in_the_Perivascular_Niche_Affects_their_Survival/22462767/1/files/39914070.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/SFigure_3_from_Macropinocytosis_of_Bevacizumab_by_Glioblastoma_Cells_in_the_Perivascular_Niche_Affects_their_Survival/22462767/1/files/39914070.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008609707","display_name":"Gaelle M. Muller-Greven","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ga\u00eblle M\u00fcller-Greven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022344420","display_name":"Cathleen R. Carlin","orcid":"https://orcid.org/0000-0002-3569-4247","observed_orcids":["https://orcid.org/0000-0002-3569-4247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cathleen R. Carlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112252229","display_name":"Monica E. Burgett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica E. Burgett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035416012","display_name":"Manmeet Singh Ahluwalia","orcid":"https://orcid.org/0000-0003-3794-9511","observed_orcids":["https://orcid.org/0000-0003-3794-9511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manmeet S. Ahluwalia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051304324","display_name":"Adam J. Lauko","orcid":"https://orcid.org/0000-0001-5654-0784","observed_orcids":["https://orcid.org/0000-0001-5654-0784","https://orcid.org/0000-0003-2288-2561"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Lauko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029650557","display_name":"Amy S. Nowacki","orcid":"https://orcid.org/0000-0002-1216-1448","observed_orcids":["https://orcid.org/0000-0002-1216-1448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy S. Nowacki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019313069","display_name":"Cameron J. Herting","orcid":"https://orcid.org/0000-0002-4937-8392","observed_orcids":["https://orcid.org/0000-0002-4937-8392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cameron J. Herting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036874457","display_name":"Maha A. Qadan","orcid":"https://orcid.org/0000-0002-7478-5723","observed_orcids":["https://orcid.org/0000-0002-7478-5723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maha A. Qadan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068526964","display_name":"Markus Bredel","orcid":"https://orcid.org/0000-0002-1436-2526","observed_orcids":["https://orcid.org/0000-0002-1436-2526","https://orcid.org/0000-0002-7828-0984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus Bredel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003857089","display_name":"Steven A. Toms","orcid":"https://orcid.org/0000-0001-8732-0522","observed_orcids":["https://orcid.org/0000-0001-8732-0522","https://orcid.org/0000-0002-2328-7994"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven A. Toms","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004589257","display_name":"Justin Durla Lathia","orcid":"https://orcid.org/0000-0003-3168-7290","observed_orcids":["https://orcid.org/0000-0003-3168-7290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin D. Lathia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054739540","display_name":"Dolores Hambardzumyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dolores Hambardzumyan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jann N. Sarkaria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006614002","display_name":"Petra Hamerlik","orcid":"https://orcid.org/0000-0002-5856-0161","observed_orcids":["https://orcid.org/0000-0002-5856-0161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petra Hamerlik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072455626","display_name":"Candece L. Gladson","orcid":"https://orcid.org/0000-0002-7651-4046","observed_orcids":["https://orcid.org/0000-0002-7651-4046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Candece L. Gladson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.6977999806404114,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.21690000593662262,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.01979999989271164,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macropinocytosis","display_name":"macropinocytosis","score":0.968999981880188},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/perivascular-niche","display_name":"perivascular niche","score":0.9200000166893005},{"id":"https://openalex.org/keywords/rab4","display_name":"Rab4","score":0.8090000152587891},{"id":"https://openalex.org/keywords/lamp1","display_name":"LAMP1","score":0.996999979019165},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.7929999828338623},{"id":"https://openalex.org/keywords/drug-trafficking","display_name":"drug trafficking","score":0.7400000095367432},{"id":"https://openalex.org/keywords/cd133-cells","display_name":"CD133+ cells","score":0.7929999828338623},{"id":"https://openalex.org/keywords/tumor-survival","display_name":"tumor survival","score":0.42500001192092896},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6545237302780151},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.637272834777832},{"id":"https://openalex.org/C40017333","wikidata":"https://www.wikidata.org/wiki/Q321362","display_name":"Pinocytosis","level":4,"score":0.5979981422424316},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5756667852401733},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5150234699249268},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5082168579101562},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.49331751465797424},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4331582188606262},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39651787281036377},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.38700979948043823},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.328590452671051},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.323868989944458},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3210102319717407},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30155545473098755},{"id":"https://openalex.org/C28005876","wikidata":"https://www.wikidata.org/wiki/Q189814","display_name":"Endocytosis","level":3,"score":0.20524516701698303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14868825674057007},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11218640208244324},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.06543999910354614},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22462767.v1","doi":"https://doi.org/10.1158/1078-0432.22462767.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22462767.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/SFigure_3_from_Macropinocytosis_of_Bevacizumab_by_Glioblastoma_Cells_in_the_Perivascular_Niche_Affects_their_Survival/22462767/1/files/39914070.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22462767","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/SFigure_3_from_Macropinocytosis_of_Bevacizumab_by_Glioblastoma_Cells_in_the_Perivascular_Niche_Affects_their_Survival/22462767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22462767.v1","doi":"https://doi.org/10.1158/1078-0432.22462767.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22462767.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/SFigure_3_from_Macropinocytosis_of_Bevacizumab_by_Glioblastoma_Cells_in_the_Perivascular_Niche_Affects_their_Survival/22462767/1/files/39914070.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.766700029373169}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361922014.pdf","grobid_xml":"https://content.openalex.org/works/W4361922014.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1146664328","https://openalex.org/W3142026086","https://openalex.org/W1462392127","https://openalex.org/W2028827184","https://openalex.org/W2146312028","https://openalex.org/W79537541","https://openalex.org/W1974849170","https://openalex.org/W3146277049","https://openalex.org/W4200337742","https://openalex.org/W2767564966"],"abstract_inverted_index":{"Figure":[0],"S3":[1],"shows":[2],"co-localization":[3],"of":[4,7,24,39],"different":[5],"fractions":[6],"bevacizumab":[8],"or":[9,15],"human":[10],"IgG":[11,28],"(hIgG)":[12],"with":[13],"Rab4":[14],"LAMP1":[16],"in":[17,21,29,33,41],"CD133+":[18],"GBM":[19,40],"cells":[20],"vitro,":[22],"and":[23],"rat":[25],"anti-mouse":[26],"VEGF-A":[27],"an":[30],"established":[31],"tumor":[32],"the":[34],"immune":[35],"competent":[36],"mouse":[37],"model":[38],"vivo,":[42],"show":[43],"similar":[44],"trafficking":[45],"patterns.":[46]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2025-10-10T00:00:00"}